Our findings here suggest that high APOBEC3B mRNA expression is associated with aggressive phenotypes, high frequency of TP53 mutation, and poor prognosis of breast cancer, especially for ER+ breast cancer. The gene discussed is APOBEC3B; the disease is breast carcinoma.